Cargando…

The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

Neuroblastoma is the most common extracranial solid tumor in childhood and arises from neural crest cells of the developing sympathetic nervous system. Prostaglandin E(2) (PGE(2)) has been identified as a key pro-inflammatory mediator of the tumor microenvironment (TME) that promotes neuroblastoma p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proestler, Eva, Donzelli, Julia, Nevermann, Sheila, Breitwieser, Kai, Koch, Leon F., Best, Tatjana, Fauth, Maria, Wickström, Malin, Harter, Patrick N., Kogner, Per, Lavieu, Grégory, Larsson, Karin, Saul, Meike J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507178/ https://www.ncbi.nlm.nih.gov/pubmed/37731742 http://dx.doi.org/10.3389/fphar.2023.1183720

Ejemplares similares

Small extracellular vesicle‐derived miR‐574‐5p regulates PGE2‐biosynthesis via TLR7/8 in lung cancer
por: Donzelli, Julia, et al.
Publicado: (2021)

Extracellular miR-574-5p Induces Osteoclast Differentiation via TLR 7/8 in Rheumatoid Arthritis
por: Hegewald, Anett B., et al.
Publicado: (2020)

SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro
por: Tümmler, Conny, et al.
Publicado: (2019)

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
por: Dyberg, Cecilia, et al.
Publicado: (2016)

The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
por: Carlson, Lena-Maria, et al.
Publicado: (2013)

Detailed Characterization of Small Extracellular Vesicles from Different Cell Types Based on Tetraspanin Composition by ExoView R100 Platform
por: Breitwieser, Kai, et al.
Publicado: (2022)

Memorandum 574
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1996)

Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo
por: Tümmler, Conny, et al.
Publicado: (2017)

Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
por: Velentza, Lilly, et al.
Publicado: (2023)

Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
por: Johnsen, John Inge, et al.
Publicado: (2019)

Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas
por: Kiss, Nimrod B, et al.
Publicado: (2012)

Neuroblastoma-related inflammation: May small doses of aspirin be suitable for small cancer patients?
por: Carlson, Lena-Maria, et al.
Publicado: (2013)

Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth
por: Kock, Anna, et al.
Publicado: (2018)

Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells
por: Emmerich, Anne C., et al.
Publicado: (2020)

Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas
por: Fransson, Susanne, et al.
Publicado: (2013)

Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene
por: Djos, Anna, et al.
Publicado: (2013)

The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma
por: Keane, Simon, et al.
Publicado: (2021)

Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors
por: Olsson, Maja, et al.
Publicado: (2016)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
por: Dyberg, Cecilia, et al.
Publicado: (2019)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

574 The Impact of Age on Wound Healing Progression in Burns
por: Pignet, Anna-Lisa, et al.
Publicado: (2023)

The immune cell atlas of human neuroblastoma
por: Verhoeven, Bronte Manouk, et al.
Publicado: (2022)

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
por: Snapkov, Igor, et al.
Publicado: (2016)

Filamin A increases aggressiveness of human neuroblastoma
por: Bandaru, Sashidar, et al.
Publicado: (2022)

The cyclin dependent kinase inhibitor p21(Cip1/Waf1) is a therapeutic target in high-risk neuroblastoma
por: Sorteberg, Agnes Luise, et al.
Publicado: (2022)

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
por: Carén, Helena, et al.
Publicado: (2011)

574 Want some s’more? The hidden risks of marshmallows
por: Ghini, Francesca, et al.
Publicado: (2022)

Artificial Tumor Microenvironments in Neuroblastoma
por: Quinn, Colin H., et al.
Publicado: (2021)

Integrative discovery of treatments for high-risk neuroblastoma
por: Almstedt, Elin, et al.
Publicado: (2020)

Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
por: Cetinkaya, Cihan, et al.
Publicado: (2013)

Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma
por: Martinez-Monleon, Angela, et al.
Publicado: (2023)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
por: Eissler, Nina, et al.
Publicado: (2014)

Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
por: Bjellerup, P, et al.
Publicado: (2000)

574. Late Diagnosis of HIV in South Carolina: Prevalence, Cause, and Consequences
por: Hossain, Akhtar, et al.
Publicado: (2018)

SUN-574 A1AT: Novel Inhibitor of Active PCSK9
por: Melendez, Quantil, et al.
Publicado: (2020)

ODP574 Characteristics of Grave's Disease Among Children and Adolescents in KSA
por: Alradadi, Rasha, et al.
Publicado: (2022)

The Regulatory Mechanism of miR-574-5p Expression in Cancer
por: Huang, Wei, et al.
Publicado: (2022)

A New Player in Neuroblastoma: YAP and Its Role in the Neuroblastoma Microenvironment
por: Shim, Jenny, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_juhna526bucufgf7kaudu5u13j